SuperworthPrecision Optics profit margin POCI
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- −11.5%
- Operating margin, 12 months
- −11.1%
- Net margin on a year earlier
- +18.8 pts
- Peer median
- 6.8%
Over the twelve months to Jun 30, 2026, Precision Optics kept −11.5% of its revenue as net profit, with an operating margin of −11.1% and a gross margin of 17.2%.
Five years earlier its net margin was −1.0%.
The median for 10 healthcare stocks of a similar size is 6.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2026 | −11.5% | −11.1% | 17.2% |
| FY2025 | −30.3% | −29.1% | 17.8% |
| FY2024 | −15.4% | −14.3% | 30.3% |
| FY2023 | −0.7% | −3.0% | 36.8% |
| FY2022 | −5.9% | −9.7% | 31.4% |
| FY2021 | −1.0% | −8.5% | 32.2% |
| FY2020 | −14.4% | −14.3% | 33.9% |
| FY2019 | −9.0% | −9.0% | 31.2% |
| FY2018 | −8.7% | −8.6% | 36.7% |
| FY2017 | −31.9% | −31.8% | 24.5% |
| FY2016 | −26.4% | n/a | 24.1% |
| FY2015 | −30.1% | n/a | 20.4% |
| FY2014 | −31.8% | −31.8% | 21.9% |
| FY2013 | −70.9% | −48.9% | 26.0% |
| FY2012 | 44.6% | −59.7% | 25.9% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q4 FY26 | −11.5% | +18.8 pts | −11.1% | |
| Q3 FY26 | −17.0% | +15.8 pts | −16.4% | |
| Q2 FY26 | −28.3% | −6.9 pts | −27.6% | |
| Q1 FY26 | −28.3% | −8.3 pts | −27.3% | |
| Q4 FY25 | −30.3% | −14.8 pts | −29.1% | |
| Q3 FY25 | −32.8% | −24.4 pts | −31.5% | |
| Q2 FY25 | −21.5% | −12.5 pts | −20.2% | |
| Q1 FY25 | −20.0% | −17.8 pts | −18.8% | |
| Q4 FY24 | −15.4% | −14.8 pts | −14.3% | |
| Q3 FY24 | −8.4% | −9.5 pts | −10.2% | |
| Q2 FY24 | −8.9% | −11.4 pts | −11.5% | |
| Q1 FY24 | −2.2% | +0.5 pts | −4.6% |
Against its peers
Companies in Healthcare nearest Precision Optics' size, closest first, today.
| Company | Profit margin |
|---|---|
| POCIPrecision Optics | −11.5% |
| ATNMActinium Pharmaceuticals | n/m |
| APTAlpha Pro Tech | 6.8% |
| NEPHNephros | 8.4% |
| SPROSpero Therapeutics | 15.7% |
| LFVNLifevantage | 2.8% |
| ICCCImmucell | 2.6% |
| KEQUKewaunee Scientific | 3.0% |
| PDEXPro DEX | 17.6% |
| PLXProtalix BioTherapeutics | 23.5% |
| NATRNatures Sunshine Products | 3.7% |
| Peer median | 6.8% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Precision Optics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.